Verified July 2026 · Cited to primary sources

Tesamorelin: Evidence Grade A. FDA-approved / proven in humans.

An FDA-approved peptide drug, not a research chemical. Proven to cut visceral fat, but approved for a narrow HIV indication.

Grade AFDA-approvedSafety: green

Legal access route

Peter MD

$90 to $300 per program (Katalys CPA band)

Check Peter MD

The honest verdict

Tesamorelin is an FDA-approved drug (Egrifta, 2010): Grade A, the strongest evidence tier here. But it is approved for HIV-associated visceral fat, not general weight loss; for that, approved GLP-1s are the evidence-backed route.

Tesamorelin at a glance

Class
Synthetic GHRH (growth-hormone-releasing hormone) analog
Mechanism
A GHRH analog that stimulates the pituitary to release growth hormone, which reduces visceral (abdominal) fat.
Also known as
Egrifta, TH9507
Research applications
  • HIV-associated visceral fat reduction (its FDA-approved indication)
  • Body recomposition / visceral fat loss (off-label)
Forms
subcutaneous injection
Legal status
FDA-approved
WADA (anti-doping)
Prohibited (S2, GHRH analog) at all times
Evidence grade
Grade AFDA-approved / proven in humans

How we grade evidence

Every grade comes from a fixed A to F rubric: human-trial strength, not hype or affiliate status. Last verified July 6, 2026.

What is Tesamorelin?

Compound class: Synthetic GHRH (growth-hormone-releasing hormone) analog

A GHRH analog that stimulates the pituitary to release growth hormone, which reduces visceral (abdominal) fat.

How strong is the evidence for Tesamorelin?

Grade A: FDA-approved (2010) on multiple pivotal Phase 3 RCTs (rule 1 fired: FDA-approved for ≥1 indication). The only currently-marketed FDA-approved GHRH analog.

Primary sources (3)

  1. Drugs@FDA: Egrifta (tesamorelin) approval record
  2. WADA Prohibited List (S2, GHRH analog)
  3. Falutz et al., N Engl J Med 2007: tesamorelin pivotal Phase 3 (n=412)

What is Tesamorelin used for?

Tesamorelin is marketed for the goals below. See how it ranks against other peptides in each, by evidence, not hype.

What does Tesamorelin cost, and how do you access it legally?

Typical cost

High. Branded Egrifta commonly $3,000+/month retail

Branded Egrifta retail is high ($3,000+/month; verify current list price). Compounded tesamorelin is cheaper but variable. Approved indication is HIV-associated visceral fat, not general weight loss.

Legal access routes

Peter MD

telehealth

$90 to $300 per program (Katalys CPA band)

Check Peter MD

Marek Health

telehealth

Membership + labs; pricing varies by protocol

Check Marek Health

Hone Health

telehealth

$30 to $75 per program (Katalys CPA band) + at-home labs

Check Hone Health

Ways2Well

telehealth

Protocol-based pricing; consult required

Check Ways2Well

Some links are affiliate links, so we may earn a commission at no cost to you. Access routes are legit telehealth and clinics, never gray-market vendors. How this works.

Trying to lose weight?

For weight loss, an approved GLP-1 beats this peptide.

No research peptide here has proven, legally-available weight-loss data that beats an approved GLP-1. Our sister site compares the options that actually work.

Compare GLP-1 options →

Is Tesamorelinsafe? Side effects & risks

Well-characterized human safety (FDA-approved or long clinical history)

Well-characterized in trials. Glucose intolerance/insulin resistance, injection-site reactions, fluid retention. Contraindicated in active malignancy and pregnancy. WADA-prohibited (S2).

Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.

Free tool

Peptide reconstitution calculator

Enter the mg in the vial and the ml of bacteriostatic water, and get the concentration plus the units to draw on an insulin syringe. It does the arithmetic on your numbers, and it never suggests a dose. See all four calculators.

Open the calculator →

FAQ

Tesamorelin FAQ

Is tesamorelin FDA approved for weight loss?

Tesamorelin is FDA-approved (as Egrifta) to reduce excess visceral abdominal fat in HIV-associated lipodystrophy, not for general weight loss. It does reduce visceral fat in that population (Grade A), but using it for everyday weight loss is off-label. For proven general weight loss, see our GLP-1 guidance.

How much does tesamorelin cost?

Branded Egrifta commonly runs $3,000+ per month at retail. Compounded tesamorelin is cheaper but variable in price and quality. Check current pricing with a licensed provider.

Is tesamorelin banned in sport?

Yes. As a GHRH analog it is on the WADA Prohibited List under S2.

From our portfolio

Tracking Tesamorelin?

Titrate is an iOS app for logging doses, schedules and progress over time, with a reconstitution calculator built in. It tracks, it does not prescribe.

Get Titrate for iOS →

Compare Tesamorelin with…

Head-to-head evidence-grade matchups people weigh against Tesamorelin.

Keep reading

The monthly peptide evidence brief.

What the research and the FDA actually say, in one short email a month. Unsubscribe anytime.

No spam. We never sell your email. Editorial policy.